Ledger.Open graph →
SEC Form D · Amendment · filed November 6, 2020

Frontier Medicines Corp

Offering
$67.0M
Sold
$67.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Othman Laraki · SOUTH SAN FRANCISCO, CADirectorKevin Webster · SOUTH SAN FRANCISCO, CAExecChris Varma, Ph.D · SOUTH SAN FRANCISCO, CAExec · DirectorCameron Wheeler · SOUTH SAN FRANCISCO, CADirectorJanwillem Naesens · SOUTH SAN FRANCISCO, CADirectorLuke Evnin · SOUTH SAN FRANCISCO, CADirectorJim Winkler · SOUTH SAN FRANCISCO, CAExecJohannes Hermann, Ph.D · SOUTH SAN FRANCISCO, CAExecDavid M. Battle, Jr · Atlanta, GAExecJeananne Hauswald · Vancouver, British Columbia, CanadaExecMichael C. Whisner · EVANSTON, ILDirectorRichard Goldfarb · Vancouver, British Columbia, CanadaDirectorLeslie E. Bradford · New York, NYDirectorPeter Bures · Vancouver, British Columbia, CanadaDirectorThomas M. Hennigan · New York, NYExecNigel D. Andrews · New York, NYExec · DirectorCarlos, Jr. J. Rodriguez · Coral Gables, FLExec · DirectorDavid J. Buddemeyer · Coral Gables, FLDirectorCarlos, Sr. J. Rodriguez · Coral Gables, FLExecConner Galloway · FOSTER CITY, CADirectorAlexander Valys · FOSTER CITY, CADirectorBob Fraser · Overland Park, KSDirectorGangadhara Ganapati · Palo Alto, CAExecBlair E. Richardson · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗